- Home
- NBRG vs CLNN Comparison
NBRG vs CLNN Comparison
Compare NBRG & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$6.11
Company Overview
Basic Information| Metric | NBRG | CLNN |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | Hong Kong | United States |
| Employees | N/A | 79 |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.5M | 85.7M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBRG | CLNN |
|---|---|---|
| Price | $9.96 | $6.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $33.75 |
| AVG Volume (30 Days) | 1.3K | ★ 671.8K |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | N/A | $19,516.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.59 | $3.25 |
| 52 Week High | $9.96 | $13.50 |
Technical Indicators
Market Signals| Indicator | NBRG | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 70.52 | 44.91 |
| Support Level | $9.90 | $5.56 |
| Resistance Level | N/A | $6.92 |
| Average True Range (ATR) | 0.01 | 0.53 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 99.78 | 20.03 |
Price Performance
Historical Comparison NBRG
CLNN
About NBRG Newbridge Acquisition Limited Class A Ordinary Share
Newbridge Acquisition Ltd is a blank check company.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.